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Abstract DNA methylation is presently accepted as a
tentative regulatory parameter in splicing. Recently, we
reported significant methylation differences among various
exonic splicing-enhancing elements and alternative splic-
ing events, based on CpG methylation data from the
Human Epigenome Project for chromosomes 6, 20 and 22.
Presently, using a different computational approach and
the same database, we report: (a) significant increase of
hypermethylation in intronic and exonic sequences close to
acceptor sites, relative to overall introns and exons,
respectively (1,973 CpGs examined); (b) frequent CpGs,
mostly hypomethylated, in donors and infrequent CpGs
mostly hypermethylated, in acceptors; and (c) hyperme-
thylation in cassette exons which are occasionally spliced
and have weaker average splicing potential, relative to
constitutive exons (p \ 0.0001). CpGs are hypomethylated
in non-coding exons (only 16 % hypermethylation). Sin-
gle-exon genes, similarly to first exons, frequently contain
hypomethylated CpGs, while in internal and last exons
CpGs are more frequently hypermethylated. Methylation is
also more frequent in strange introns and splice sites pro-
cessed by the minor spliceosome, e.g., ATAC, (p \ 0.0001
in all cases), but not in sites of incomplete processing, e.g.,
retained introns or bleeding exons, (p = 0.706 and
p = 0.313, respectively). Most Alus, which are known
to contribute to transcript presentation, are heavily
methylated, in contrast with other Alus, e.g., AluJo and
mammalian interspersed repetitive elements which have
been previously associated with alternative expression.
These results elucidate the role of intragenic methylation in
association with alternative splicing and facilitate the
evaluation of genomic variations/polymorphisms and the
development of tools for the prediction of alternative
splicing events.
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Introduction
Although epigenetic mechanisms are actively investigated
at present, our understanding of the impact of non-pro-
moter DNA methylation is still very limited. Recently, it
has become increasingly evident that DNA methylation
might be a key parameter in the process of splicing (Luco
et al. 2011). This novel role for DNA methylation, which is
based on the finding that splicing is a co-transcriptional
process (Pandya-Jones and Black 2009; Tilgner and Guigo
2010), is expected to provide a better understanding of the
splicing mechanisms and differentiation of gene expression
(Pandya-Jones and Black 2009).
In fact, the possible involvement of DNA methylation in
the regulation of the splicing process has been recently
addressed. Specifically, the studies of Chodavarapu et al.
on Arabidopsis thaliana reveal that DNA methylation is
highly enriched in exons and nucleosome positioning
might play a significant role in DNA methylation (Chod-
avarapu et al. 2010), which, in turn, is associated with the
selection of intron–exon boundaries (Schwartz and Ast
2010; Tilgner and Guigo 2010; Choi 2010). Transitions in
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the methylation state correlating with genomic landmarks
such as intron–exon junctions were reported by Hodges
et al. (2009) based on single molecule human DNA studies.
Finally, the role of DNA methylation in alternative splicing
is supported by the recent work of Shukla et al. (2011) in
CD45 cells. In this work, the authors showed that the
activity of the CCCTC-binding factor (CTCF), which can
promote inclusion of weak upstream exons by mediating
local RNA polymerase II pausing, can be reciprocated by
DNA methylation in a specific exon.
Correlation of the CpG density/methylation state with
expression in alternatively spliced sequences is therefore
critical for elucidating the epigenetic regulatory mecha-
nisms in splicing. CpG-dense motifs (Malousi et al. 2008)
and specific Alu repeats, e.g., Alujb, AluSx and AluJo
(Sorek et al. 2002, 2004) have been strongly associated
with alternative splicing. In addition, the latter have been
proposed to cause frame-shifting or premature termination
codons, reduced expression frequencies (Lin et al. 2008) in
different pathological conditions, such as X-linked dilated
cardiomyopathy (Rimessi et al. 2010), ATM (Pastor et al.
2009) and other human diseases (Vorechovsky 2010).
Similarly, mammalian interspersed repeats (MIRs) have
been associated with frequently diverse, translational reg-
ulation (Huh et al. 2008; Lin et al. 2008).
These observations are in support of a new model for the
regulation of splicing, in which DNA methylation plays an
important role in constitutive and alternative splicing.
More specifically, chromatin remodeling via chromatin-
binding proteins such as CTCF, or other protein factors
appears to be also related to polymerase stalling, which in
turn, is necessary for transcriptional elongation and splic-
ing (Tao et al. 2010; Shukla et al. 2011; Alexander et al.
2010; Oberdoerffer 2012). In addition, nucleosomal posi-
tioning, which has been associated with polymerase
activity regulation, is reported to be preferentially associ-
ated with methylated sequences (Chodavarapu et al. 2010;
Shukla et al. 2011). This data, which combines nucleo-
somal positioning and polymerase activity with splicing
efficiency and DNA methylation reveals an immersing role
for DNA methylation, related to splice site selection, and
possibly alternative splicing. Such a model would in turn
provide a better interpretation of disease-related mutations
and polymorphism selection (Karambataki et al. 2010).
However, to date, there is little direct information from
large-scale data on the association of methylation with
specific alternative splicing types, splice sites and short
interspersed nuclear elements (SINEs), as well as the dis-
tribution of methylation in splice sites.
A recent analysis (Anastasiadou et al. 2011) based on
the methylation data obtained for 33,352 CpG sequences
from different human tissues reported by the Human Epi-
genome Project (HEP), showed that DNA methylation is
significantly associated with alternative splicing events and
varies among different categories of exonic motifs (exonic
splicing enhancers), which play a regulatory role in splic-
ing. Using a different computational procedure and the
same raw data from a variety of tissues, we presently
investigated CpG methylation in introns, splice sites, and
different SINEs. Moreover, we examined its presence with
respect to different forms of alternative splicing events.
Our present results provide considerable insight on the
association of methylation with splicing selection and
promote our understanding of alternative splicing.
Materials and methods
The present study is based on computational analyses of
DNA methylation data from HEP (Rakyan et al. 2004;
Eckhardt et al. 2006). HEP is the first systematic and large-
scale study of DNA methylation on the human genome that
aims to map DNA methylation sites through the 30,000
gene loci. Specifically, we used the 26th release of the HEP
pilot data (June 2006) containing the methylation status of
1.88 million CpG sites that were obtained from the analysis
of 2,524 amplicons of human chromosomes 6, 20 and 22.
In order to examine potential co-localization of the analyzed
CpG sites and regulatory elements affecting gene expres-
sion, we mapped genomic regions of interest (hg16 genome
assembly, July 2003), e.g., transcribed sites, repeats and
alternative splicing events to the available methylation sites
together with the assigned average methylation scores from
12 tissues ranging from 0 to 100 % for each record. CpG
sites with known data that was not further analyzed by the
HEP Project and data with no available methylation score
was ignored.
We classified the resulted 33,352 CpGs with recorded
methylation score, including zero methylation, in three
categories depending on their average methylation values.
CpG sites with methylation score greater or equal to 80 %
(9,012 sites) belong to the dataset of the hypermethylated
cytosines (HmC), while CpGs with methylation scores
ranging from zero up to 20 % (15,296 sites) are charac-
terized as hypomethylated or low-methylated (LmC). The
remaining 9,044 methylation data with methylation levels
between 20 and 80 % correspond to a third category con-
taining data with intermediate methylation scores (ImC).
This classification has been also applied in other studies
and can safely distinguish sequences containing HmC and
LmC (Rakyan et al. 2004; Eckhardt et al. 2006).
In the analysis of the 60-nt sequences centered at
the splice junctions that contain HmC, ImC or LmC we
extracted all hg16 introns, rather than exons, and retrieved
their flanking sequences in order to avoid the selection of
splice sites preceding and following first and last exons,
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respectively. Introns and exons of less than 30 nt were
excluded in this study in order to avoid overlaps between
consecutive splice sequences. Similarly, in the analysis of
the 130 nt intronic sequences flanking donor and acceptor
sites, overlapping sequences were excluded. The UCSC
Table Browser (Karolchik et al. 2004) through the Galaxy
platform (Goecks et al. 2010) was used to extract the
coordinates and the sequences of the examined regions and
the Galaxy’s lift-over tool was used to map genomic
coordinates between different assemblies, where needed.
The set of 27,866 constitutive exons is a compilation of
all hg16 reference exons subtracted by the 8,735 alternative
splicing events that were extracted from the UCSC altE-
vents track of the same human genome assembly. In
addition, the Repeatmasker track of the UCSC Table
Browser (Smit AFA 1996–2007) was used to screen
annotated SINEs in chromosomes 6, 20 and 22 (hg16
human genome assembly). Finally, for the combined
analysis of the methylation and genomic data we developed
Perl scripts and for the statistical evaluation of the identi-
fied associations we employed Chi-square and t tests.
Results
Methylation in transcribed sequences of chromosomes
6, 20 and 22
The proposed computational approach was first applied on
the adjusted HEP data in order to measure the distribution
of methylation in exons compared to introns (Table 1).
Exonic CpGs were divided in two categories: coding and
non-coding. The latter are mostly positioned at both ends
of the transcribed sequences and play a regulatory role in
expression (Lilischkis et al. 2001; Medvedeva et al. 2010).
This analysis reveals, as expected (Hodges et al. 2009;
Chodavarapu et al. 2010), significant hypermethylation
(HmC, 48 %) among coding exons, while CpG-containing
sequences in introns are less frequently hypermethylated
(HmC, 24 %; Fig. 1). It should be noted, however, that since
all presently examined intronic and exonic sequences are
CpG-containing, while introns also contain extended CpG-
free sequences, the actual intronic methylation frequency is
probably lower than that presently shown in Table 1. The
results in Table 1 also show that a substantial number of the
examined methylated CpGs are included in non-coding
exons, and the size of this sample is suitable for valid sta-
tistical comparisons. In this case, CpGs in non-coding exons
are scarcely hypermethylated (HmC, 16 %; Fig. 1).
We then analyzed the frequencies of hypermethylated,
occasionally methylated and hypomethylated CpGs (HmC,
ImC and LmC, respectively), in different exonic and intronic
sequences. For this purpose, the CpGs of each of the above
categories were divided by the corresponding number of
non-duplicated sequences containing at least one CpG in the
corresponding category (Fig. 2). In addition, exonic
sequences were classified as initial, terminal, single and
internal exons. Initial and terminal exons (mostly non-cod-
ing) are more CpG-dense compared to internal (coding)
exons (total number of CpGs per number of sequences:
20.55 for initial, 22.08 for terminal exons, 16.10 for internal,
and 26.75 for single exons), while initial exons are also more
hypomethylated compared to intronic sequences.
The hypermethylation frequency in initial exons is
comparable to that in introns (Fig. 2). Single exons have
common epigenetic characteristics both with initial and
partially with internal exons. Specifically, the average
number of hypermethylated CpGs per sequence is similar
in single and internal exons, but single, similarly to initial
exons, also have higher LmC frequencies and are more
CpG-dense than other exons. In addition, they share similar
average numbers of CpG sites per sequence of variable
methylation with terminal exons.
Table 1 Number of methylated CpGs in selected sequences












HmC 9,012 3,644 2,915 729 2,844
ImC 9,044 2,167 1,336 831 3,219
LmC 15,296 4,795 1,788 3,007 5,553
Total 33,352 10,606 6,039 4,567 11,616
Multiple CpGs may be located in a single sequence
a The number of non-coding exons resulted by subtracting the coding
exons from exons
Fig. 1 Methylation frequencies
(obtained from data in Table 1)
in exons, coding exons, non-
coding exons, and introns
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Overall, the data in Table 1 and Fig. 2 show that, in
addition to dense exonic versus poor intronic methylation,
limited methylation close to the transcription start site is
probably required to establish the transcription process,
while high CpG density is necessary to block transcription
initiation or to terminate it (in single exons and in terminal
exons, respectively), when required. Furthermore, this data
might also indicate that high, possibly specific methylation,
is required to regulate transcription of single, initial, ter-
minal exons. In internal exons, where the average hyper-
methylation per sequence is high, though considerably
lower than in terminal exons the CpG density is lower
possibly introducing a transient halt during transcription. In
this case the presence of methylation might be also asso-
ciated with the spliceosome formation (Oberdoerffer 2012;
Anastasiadou et al. 2011).
Distribution of methylation in donors and acceptors
The distribution of methylation and the CpG frequencies in
splice sites were evaluated with respect to the position of
each analyzed CpG relative to the intron/exon boundaries.
These sites have been previously shown to be associated
with distinct methylation transitions in single cell experi-
ments (Hodges et al. 2009). Figure 3a illustrates the dis-
tribution for each methylation level in donors and acceptors
in 20 nt sliding windows. In total, 1,973 CpGs (763 HmC,
491 ImC and 719 LmC) were identified in 60 nt regions
centered at splice junctions. At the splice donor sequence
corresponding to the U1snRNP binding site (Roca et al.
2005) the LmC frequency exhibits a local minimum com-
pared to the HmC (p = 0). In addition, the frequency of
methylated cytosines (HmC and ImC) in the intronic region
close to acceptors is also very low compared to the intronic
sites close to donors, indicating that, CpGs in donors are
frequently hypomethylated contrary to those in the corre-
sponding acceptor region (p = 0).
The hypermethylation frequency, i.e., the number of
HmC divided by the total CpGs, either HmC, ImC or LmC
identified in each region is shown in Fig. 3b. Close to the
splice junction, the hypermethylation frequency is signifi-
cantly higher at the acceptor site (both intronic and exonic)
compared to the average frequency in introns or exons
(Fig. 1). In donors, the hypermethylation frequency is
comparable to the average frequency in introns and exons.
This data reveal that, although CpGs might be frequent in
splice donors, only a small fraction is hypermethylated,
while the limited number of CpGs present in acceptors is
mostly hypermethylated. Thus, in 50 intron ends there is
probably a strict selection of CpGs undergoing methyla-
tion, while hypermethylation is very frequent in 30 intron
ends compared to all other sites examined.
We then analyzed the hypermethylation frequencies
among CpGs in the intronic sequences, flanking splice
junctions using 20-nt sliding windows (Fig. 4). Up to 90 nt
from the acceptor junction, the hypermethylation frequency
decreases but remains significantly higher compared to the
average intronic, or even to the corresponding donor sites.
Approximately 100 nt from the acceptor site the intronic
hypermethylation frequency decreases. Extending by 30 nt
this region it is evident that the HmC frequency becomes
less variable and it remains relatively low. At the donor site
the hypermethylation frequency extended in the 130-nt
intronic region is less variable than the corresponding
frequency at the acceptor site and also continuously lower
than the average frequency of introns.
Fig. 2 Average methylation per
sequence, i.e., the number of
identified HmC, ImC and LmC
versus the number of analyzed
sequences (no. of CpGs/no. of
seqs), in total, single, initial,
internal and terminal exons and
in introns, containing at least
one recorded CpG. The number
of CpGs per the number of
sequences is shown in the
embedded table
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In addition, the methylation density in the 100-nt
intronic region close to splice junctions was found to be
comparable to that in exons and approximately 100-fold
higher than the corresponding density in total intronic
sequences shown in Table 2. The density of the LmC and
partly methylated CpGs (ImC) close to the splice junctions
is very high compared to introns. On the contrary, the
hypermethylated CpG density is very low in donors
(Table 2). Thus, in 50 intron ends close to splice junctions a
strict selection of CpGs undergoing methylation, extends
Fig. 3 a Distribution of methylation at both sides of donors and
acceptors in 20-nt sliding windows of 60 nt total length centered at
the splice junctions. The exon–intron boundaries are shown in vertical
dashed lines. b Hypermethylation frequency corresponding to the
same region shown in a. The average HmC frequency in whole exons
and introns is shown in horizontal lines (obtained from Fig. 1)
Fig. 4 Hypermethylation frequency in the 130-nt intronic sequences flanking donor (left) and acceptor (right) sites, using 20-nt sliding windows.
The average HmC frequency in introns, obtained from Fig. 1, is shown in horizontal lines
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for at least 100 nt within introns, while the probability of
hypermethylation within acceptor CpGs is higher than in
any other site presented in Table 1.
Provided that previous studies based on a single cell
analysis (Hodges et al. 2009) have shown sharp methyla-
tion changes in intron/exon boundaries, it is conceivable
that the presently shown high methylation scores and slow
demethylation transitions in intron/exon boundaries, are
related to the fact that this analysis is based on average
methylation frequencies for all tissues and cells. Together,
these results show that methylation in the 100-nt edges of
intronic sequences is probably very significant and selec-
tive for determining the ‘‘epitype’’ (Hodges et al. 2009),
i.e., epigenetic regulation and splice site selection in indi-
vidual tissues.
Methylation and alternative splicing
Methylation frequencies in cassette and constitutive exons
We then tested whether the methylation frequency might
be altered in association with alternatively spliced
sequences such as cassette exons, exons with weak, non-
canonical splice sites, or in splice sites processed by the
minor spliceosome. For this purpose, sequences containing
CpGs with recorded methylation data were further ana-
lyzed for their presence in alternatively spliced forms. The
most frequently observed alternative splicing events
involve cassette exons which exhibit well-defined intron-
exon boundaries and are characterized by lower splicing
potential (scores) compared to constitutive exons (Clark
and Thanaraj 2002; Garg and Green 2007).
As shown in Table 2, the density of hypomethylated
CpGs is higher in the 990 analyzed constitutive exons
(1.67 % LmC vs. 0.95 and 0.54 % for HmC and ImC,
respectively), while the hypermethylation density is higher
in cassette (64 in total) than constitutive exons (2.59 vs.
0.95 %, respectively). Thus, cassette exons are character-
ized by a considerable increase of the methylation density,
while their total CpG density does not significantly vary
from that of constitutive exons. Although the sample of
cassette LmC is limited, the methylation differences of
HmC and LmC between total exons and cassette sequences
are very significant (p \ 0.0001; Table 3).
The above findings (summarized in Fig. 5) reveal that
significant methylation differences are observed between
alternative and constitutive exons depending on the type of
alternative splicing process. Particularly prominent is also
the ‘‘infiltration of methylation’’ in intronic sequences
neighboring splice junctions and the methylation differ-
ences between donors and acceptors. Information regarding
alternative splicing in association with the distribution of
methylation in exonic splicing enhancers (Anastasiadou
et al. 2011) will facilitate the design of improved compu-
tational tools for alternative splice site prediction (Richard
et al. 2010; Wang and Marin 2006) and evaluation of
disease-related mutations and polymorphisms (Kouidou
et al. 2009).
Splicing potential in cassette and constitutive exons
The flanking 50 and 30 intron ends of the analyzed cassette
and constitutive exons were then evaluated for their com-
pliance with the canonical forms, i.e., GT dinucleotides for
the following donors and AG for the preceding acceptors as
regards to their methylation and their splicing strength. The
flanking intron ends were identified in cassette and con-
stitutive exons using UCSC altEvents track in our sample
and the splicing potential of canonical splice sites was
calculated using the identification method proposed by
Shapiro and Senapathy (1987).
Using this approach we observed that 63 out of 64
cassette exons containing at least one HmC, ImC or LmC
were canonical (overlaps included), showing that the pres-
ently examined cassette exons comply with the canonical
splicing forms (p \ 0.0001). The only cassette exon with
non-canonical splice sites flanks a GC donor and AG
acceptor. Of the 990 identified constitutive exons that
contain at least one HmC, ImC or LmC (Table 4), a sub-
stantial number corresponds to first and last exons. Almost
all internal constitutive exons exhibit canonical AG/GT
intron ends (99.34 %). As expected from the results shown
in Fig. 2, we also observed that hypermethylation is fre-
quent in terminal and less prominent in initial exons, while
the opposite is found for rarely methylated CpGs (LmC).
However, intermediate methylation was equally frequent in











HmC 0.024 0.022 0.0003 0.0259 0.0095
ImC 0.021 0.018 0.0002 0.0134 0.0054
LmC 0.059 0.045 0.0005 0.0153 0.0167
Total CpGs/(number of non-duplicated sequences containing at least
one CpG 9 average length of the sequences)
Table 3 Statistical analysis of hypermethylation differences (p val-
ues) between total exons, introns relative to alternative splicing events
Total exons Total introns
Cassette exons p \ 0.0001 Retained introns p = 0.706
Bleeding exons p = 0.313 ATAC introns p \ 0.0001
Strange introns p \ 0.0001
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initial and terminal exons. Among constitutive acceptors,
methylation differences (HmC/ImC and HmC/LmC) are
statistically significant, and the same is observed in some
cases in donors (HmC/LmC). However, in donors we also
observed that there is no significant difference between the
frequency of hypermethylated CpGs (HmC) and ImCs, i.e.,
CpG cytosines which are either methylated only in specific
tissues, or at specific developmental stages. This finding
probably indicates that in donors and acceptors the meth-
ylation process is regulated by different parameters. All
other differences are statistically significant. As expected
from the results shown in Fig. 2, in constitutive terminal
exons hypermethylation is more frequent relative to initial
exons while the opposite is found for rarely methylated
CpGs (LmC). Intermediate methylation was equally fre-
quent in initial and terminal exons.
The splicing scores of the examined donors and accep-
tors also differ between cassette and constitutive exons.
Acceptors with canonical form that precede cassette exons
exhibit lower splicing scores compared to constitutive
Fig. 5 Graphical representation of methylation densities in exons (cassette, constitutive and total), introns and 100 nt 50, 30 intronic sites. The
relative widths of the different grey tones correspond to methylation frequencies. The shown frequency scale is enlarged 109 for introns








AG 295 GT 232
98.6 % (205/208) 51 (Terminal exons) 113
AT 1 AT 1






100 % (176/176)126 115
Other 0 AT 1
GC 2
LmC 260
AG 95(p = 0)* GT
201





Other 0 GC 2
(Terminal exons)
(Terminal exons)
‘‘Other’’ refers to non-canonical donors and acceptors of internal exons unless otherwise specified. Paired canonical: Exons flanked by canonical
splice sites (both acceptor and donor)
* Relative to HmC
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exons (Table 5). The data on cassette exons are in agree-
ment with previous observations by Choi (2010), which
reveal that methylation is enriched in exons with weak
splice sites and is probably associated with spliceosome
positioning and with previous findings for cassette exons
(Garg and Green 2007; Clark and Thanaraj 2002). These
data are in support of a splicing-enhancing role for exons
with weak splice sites.
Methylation in other alternatively expressed loci
In order to further verify the association of methylation with
various, less frequent types of alternatively spliced sequen-
ces (other than cassette exons), we identified the alternative
splicing events among the analyzed CpG-containing
sequences studied by HEP (hg16, July 2003) and correlated
them with the methylation status in these sequences. Spe-
cifically, each methylation locus was searched through the
list of annotated alternative splicing events. Figure 6 shows
the matched events per methylation category.
The results in Fig. 6 reveal that most significant differ-
ences in methylation are observed in specific types of
alternative splicing events, e.g., in alternative promoters, in
alternative 30 ends, and in strange introns and bleeding
exons. Specifically, Fig. 6 shows that hypermethylation is
more frequent among alternatively spliced sequences in
which the intron-exon boundaries are well defined, relative
to other splicing events defined as ‘‘bleeding’’ in which the
intron-exon boundaries are not well defined. Thus, bleeding
exons are less hypermethylated compared to cassette exons
(32.04 % HmC, vs. 60.52 % in cassette exons) or com-
pared to the average coding exons (48 %, Table 1). In
addition, other types of sequences resulting from splicing
events which are considered products of partial spliceoso-
mal processing, e.g., retained introns, are characterized by
low methylation levels (HmC, 29.03 %; LmC, 48.39 %).
In both bleeding exons and retained introns the statistical
difference with total exons and introns is not significant
(p = 0.313 and p = 0.706, respectively; Table 3). In
addition, strange introns are significantly more hyperme-
thylated than total introns (Table 1; Fig. 6) and the same is
observed with ATAC introns, a specific intron category
with non-canonical intron ends, which are processed by the
minor spliceosome (HmC, 57.14 %, similar to the fre-
quency of cassette exons), indicating that there might be a
significant correlation of methylation frequencies and
selection of different intron ends.
Once more, this type of analysis is in agreement with the
results shown in Table 1 and Fig. 2 and reinforces the
finding that methylation is significantly correlated with the
selection of expressed sequences and acts, in a sequence-
specific, orchestrated manner, depending on the splice site
acceptor and donor sequences (Tables 4, 5; Figs. 5, 6). In
contrast, ‘‘deviations’’ occurring by incomplete processing
of one exon boundary, i.e., bleeding exons, are associated
with lower methylation frequencies and other selection
processes. All previously described differences are very
significant (p values are shown in Table 3).
Methylation in SINEs
The frequency of methylation in SINEs, which are also
known regulatory parameters for transcript inclusion,
was then evaluated using RepeatMasker (Smit AFA
1996–2007) in order to identify methylation differences
which might discriminate the various SINEs relative to
their epigenetic modification state. These differences were
then compared to the previously described impact on
transcript inclusion for the different SINEs. We identified
308 SINEs containing HmC, ImC or LmC among the
167,304 detected SINEs in chromosomes 6, 20 and 22
(hg16, July 2003). The identified SINEs correspond to
0.184 % of the total SINEs in these chromosomes,
regardless of their CpG content (Table 6). Analysis of the
different SINE categories (Fig. 7) reveals a variety of
different Alus present in this sample. Among these, AluSx,
MIR and MIRb are most frequent.
Most of these SINEs are hypermethylated (HmC,
54.87 %; Table 6), but strong differences of the methylation
frequencies among Alus and particularly MIRs (Fig. 8) are
also observed. While most Alus, including AluSx, which is
the most frequent Alu present in this sample and in chro-
mosomes 6, 20 and 22 (Fig. 7), are rarely hypomethylated,
MIRs (MIR, MIR3 and MIRb), as well as AluJo are char-
acterized by lower hypermethylation frequencies (Fig. 8).
The difference of hypermethylation between the above
repeat sequences, i.e., AluJo and MIRs, relative to all the
remaining SINEs is statistically significant (p \ 0.0001).
Methylation among MIRs also varies. In view of these
Table 5 Splice site scores and average scores of the three categories




HmC 78.53 (33) 82.71 (232)
ImC 80.04 (26) 83.44 (264)
LmC 77.84 (4) 83.86 (201)
Av. score 78.80 83.34
Acceptors
HmC 48.95 (34) 54.03 (295)
ImC 49.99 (26) 54.32 (256)
LmC 46.16 (4) 54.31 (95)
Av. score 48.37 54.22
The corresponding number of exons is shown in parenthesis
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significant variations of the methylation frequencies in
AluJo and MIRs which have been previously associated
with alternative splicing (Lin et al. 2008; Shen et al. 2011)
and transcript inclusion in coding sequences, it is probable
that methylation might also contribute to the regulation of
‘‘exonization’’ in SINE-containing methylated sequences.
Discussion
Contrary to promoter methylation, the role of exonic and
intronic methylation is still ill-defined. Recent evidence
points out the association of promoter methylation with
chromatin modification, transcriptional elongation and RNA
polymerase stalling (Chen et al. 2011). This data also indi-
cates a similar role for intragenic methylation in splicing and
its regulation. Our data provides a detailed description of the
distribution of methylation and of epigenetically unmodified
CpGs in different human sequences with respect to splicing,
‘‘weak’’ and ‘‘strong’’, alternative and constitutive splice
sites, and ‘‘exonization’’ (single, initial and terminal exons,
as well as Alus which are known to contribute to ‘‘exon-
ization’’). In addition, we provide a detailed account of sites,
which are partially or rarely epigenetically modified. Based
on our results, it becomes evident that the cytosine meth-
ylation density is modified according to the transcriptional
and splicing potential of a sequence, and could thus act as a
supplementary parameter for regulating the splicing strength
of splice sites (in defining ‘‘spliceable’’ sequences). More-
over, it becomes evident that different ‘‘rules’’ regulate the
methylation frequency in donors and acceptors, as well as at
the 50, relative to the 30 ends of genes. More specifically, our
results reveal that intragenic methylation is strongly asso-
ciated with transcribed regions in which specific transcript
Fig. 6 Distribution of the
studied a HmC, b ImC and
c LmC with respect to their co-
occurrence with alternative
splicing events. The frequency
of all reported alternatively
spliced introns and exons in
chromosomes 6, 20 and 22 is
shown in d
Table 6 Total CpGs observed in SINEs and the number of SINEs
containing at least one HmC, ImC and LmC
Total CpGs in SINEs SINEs containing at least
one CpG (CpGs per SINE)
HmC 169 55 (3.07)
ImC 89 51 (1.74)
LmC 50 23 (2.17)
Total 308 129 (2.38)
The average number of CpGs per SINE sequence is shown in parenthesis
Mol Genet Genomics (2012) 287:631–642 639
123
processing is required, such as alternative exons, weak
acceptors, as well as rare ATAC introns. Epigenetic marks,
such a reduction of methylation appear to define exon/intron
boundaries. It should be noted that in a previous publication
we showed an increase of methylation in nucleosome-
binding consensus sequences, which has also recently been
shown to regulate the splicing efficiency (Anastasiadou et al.
2011).
During the preparation of this manuscript, two studies
on genome-wide methylation in rat (Sati et al. 2012), as
well as in specific cell types have been reported (Zhou et al.
2012). Although different analytical procedures have been
applied in these studies and the results are not directly
comparable, they both emphasize the role of DNA meth-
ylation in the alternative transcript inclusion. Our study
presents a detailed account of the average methylation in
more than one human tissue as well as the average degree
of methylation (hyper-, inter-, hypomethylation) for each
CpG site in different developmental stages. In conclusion,
the above data are critical for understanding the role of the
Fig. 7 Relative frequencies of
different types of SINEs in
chromosomes 6, 20 and 22.
Some Alus (AluSq/x, AluSg1,
Alu, FAM, AluYd2, AluYc2,
AluJ/FLAM, and AluYd3a1)
generally denoted as ‘other’
have frequency greater than
0.3 % (not shown)
Fig. 8 Distribution of
methylated CpGs among
different types of SINEs. The
total number of SINEs in
chromosomes 6, 20 and 22 is
167,304
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vast majority of DNA methylation, which is focused in
intragenic regions. It is, however, conceivable that meth-
ylation involving, but yet undefined regulatory regions
related to miRNA coding and other regulatory sites of the
genome is expected to play significant role in expression
and differentiation.
Moreover, we analyzed data with respect to the CpG
frequency, i.e., the number of methylation targets for each
sequence. Previous studies (Davey and Allan 2003;
Dhasarathy and Wade 2008) have shown that the presence
of CpG sequences alters the DNA conformation and
nucleosome binding independently of the methylation
density. Our detailed analysis indicates that the CpG and
methylation densities might act as independent parameters
defining the selection and efficiency of splice sites and
promoters, and the transcript inclusion of exons or intronic
sequences. In UTRs and splice donors, where transcrip-
tional stalling is required, the appropriate protein assembly
is probably dependent on the very frequent presence of
methylation and the recognition by different methyl-bind-
ing proteins (Dhasarathy and Wade 2008). Similarly,
methylation might facilitate splicing of weak splice sites
and alternatively spliced exons by assisting spliceosome
recruitment. In promoters and first exons, high CpG density
probably denotes the presence of a tentative regulatory
target, while their accessibility is regulated by methylation.
In introns where splice sites and intronic acceptors which
are CpG-poor, the chromatin architecture, looping and
absence of nucleosomes, probably facilitates spliceosome
binding and splicing. Finally, the expression of intronic
CpG-dense sites, such as Alus, might be dependent on their
methylation density. Thus, analysis of the CpG density
relative to the methylation distribution presented in this
study contributes to a better understanding of a new role of
DNA methylation in transcription and introduces new
constituents to the process of alternative splicing.
Comprehensive analysis of all available data and large-
scale studies on epigenetic modifications, are now required
to promote our understanding of the epigenetic regulation
of splicing and transcript inclusion. However, since DNA
imprinting includes several forms of epigenetic modifica-
tion, such as non-CpG methylation, also frequent in splice
sites (Shen et al. 2011), and other forms of cytosine
modification, e.g., hydroxymethylcytosine, also presently
considered critical for DNA expression (Pastor et al. 2011),
it is evident that the present data provides only ‘‘quick
glances’’ at the highly complex epigenetic code and its
impact on expression.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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